Clinical Trial Update: Ketamine and Lidocaine Infusion in Refractory Chronic Migraine [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial from Assiut University is evaluating ketamine and lidocaine infusion for refractory chronic migraine. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Ketamine (ketamine)
• Lidocaine (Lidocaine)

Snippet

Sponsor: Assiut University | Conditions: Refractory Chronic Migraine | EARLY_Phase 1 | Status: NOT_YET_RECRUITING